Benoxaprofen-induced photo-onycholysis.

Abstract	Benoxaprofen (Opren) is a nonsteroidal anti-inflammatory agent used in the treatment of arthritis. Photosensitivity, including onycholysis, has been reported in the rheumatologic literature. This drug has recently been approved for use in the United States under the name of Oraflex. In order to alert the dermatology community, we report a case of photo-onycholysis which developed in a patient being treated with benoxaprofen and review the data on this drug and its side effects.
Authors	L S McCormack, M L Elgart, M L Turner
Journal	Journal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 7 Issue 5 Pg. 678-80 (Nov 1982) ISSN: 0190-9622 [Print] United States
PMID	7142476 (Publication Type: Case Reports, Journal Article)
Chemical References	Anti-Inflammatory Agents Propionates benoxaprofen
Topics	Anti-Inflammatory Agents (adverse effects) Female Humans Middle Aged Nail Diseases (chemically induced) Photosensitivity Disorders (chemically induced) Propionates (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!